Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2005

Open Access 01-12-2005 | Research

Health-related quality of life is related to COPD disease severity

Authors: Elisabeth Ståhl, Anne Lindberg, Sven-Arne Jansson, Eva Rönmark, Klas Svensson, Fredrik Andersson, Claes-Göran Löfdahl, Bo Lundbäck

Published in: Health and Quality of Life Outcomes | Issue 1/2005

Login to get access

Abstract

Background

The aim of this study was to evaluate the association between health-related quality of life (HRQL) and disease severity using lung function measures.

Methods

A survey was performed in subjects with COPD in Sweden. 168 subjects (70 women, mean age 64.3 years) completed the generic HRQL questionnaire, the Short Form 36 (SF-36), the disease-specific HRQL questionnaire; the St George's Respiratory Questionnaire (SGRQ), and the utility measure, the EQ-5D. The subjects were divided into four severity groups according to FEV1 per cent of predicted normal using two clinical guidelines: GOLD and BTS. Age, gender, smoking status and socio-economic group were regarded as confounders.

Results

The COPD severity grades affected the SGRQ Total scores, varying from 25 to 53 (GOLD p = 0.0005) and from 25 to 45 (BTS p = 0.0023). The scores for SF-36 Physical were significantly associated with COPD severity (GOLD p = 0.0059, BTS p = 0.032). No significant association were noticed for the SF-36, Mental Component Summary scores and COPD severity. Scores for EQ-5D VAS varied from 73 to 37 (GOLD I-IV p = 0.0001) and from 73 to 50 (BTS 0-III p = 0.0007). The SGRQ Total score was significant between age groups (p = 0.0047). No significant differences in HRQL with regard to gender, smoking status or socio-economic group were noticed.

Conclusion

The results show that HRQL in COPD deteriorates with disease severity and with age. These data show a relationship between HRQL and disease severity obtained by lung function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vollmer WM, Osborne ML, Buist AS: 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. American Journal of Respiratory & Critical Care Medicine 1998, 157: 1079–1084.CrossRef Vollmer WM, Osborne ML, Buist AS: 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. American Journal of Respiratory & Critical Care Medicine 1998, 157: 1079–1084.CrossRef
2.
go back to reference Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI and WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory Care 2001, 46: 798–825.PubMed Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI and WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory Care 2001, 46: 798–825.PubMed
3.
go back to reference BTS: BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997, 52: S1–28. BTS: BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997, 52: S1–28.
4.
go back to reference Ray D, Abel R, Selvaraj KG: A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian Journal of Medical Research 1995, 101: 238–244.PubMed Ray D, Abel R, Selvaraj KG: A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian Journal of Medical Research 1995, 101: 238–244.PubMed
6.
go back to reference Mannino DM, Gagnon RC, Petty TL, Lydick E: Obstructive lung disease and low lung function in adults in the United States - Data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000, 160: 1683–1689. 10.1001/archinte.160.11.1683PubMedCrossRef Mannino DM, Gagnon RC, Petty TL, Lydick E: Obstructive lung disease and low lung function in adults in the United States - Data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000, 160: 1683–1689. 10.1001/archinte.160.11.1683PubMedCrossRef
7.
go back to reference Sobradillo V, Miravitlles M, Jimenez CA, Gabriel R, Viejo JL, Masa JF, Fernandez-Fau L, Villasante C: [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. Arch Bronconeumol 1999, 35: 159–166.PubMedCrossRef Sobradillo V, Miravitlles M, Jimenez CA, Gabriel R, Viejo JL, Masa JF, Fernandez-Fau L, Villasante C: [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. Arch Bronconeumol 1999, 35: 159–166.PubMedCrossRef
8.
go back to reference Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K: Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respiratory Medicine 2003, 97: 115–122. 10.1053/rmed.2003.1446PubMedCrossRef Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K: Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respiratory Medicine 2003, 97: 115–122. 10.1053/rmed.2003.1446PubMedCrossRef
9.
go back to reference Lindstrom M, Jonsson E, Larsson K, Lundback B: Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2002, 6: 76–84.PubMed Lindstrom M, Jonsson E, Larsson K, Lundback B: Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2002, 6: 76–84.PubMed
10.
go back to reference Tirimanna PRS, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CLA, van den Boom G, van Grunsven PM, van den Bosch WJHM: Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract 1996, 46: 277–281.PubMedCentralPubMed Tirimanna PRS, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CLA, van den Boom G, van Grunsven PM, van den Bosch WJHM: Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract 1996, 46: 277–281.PubMedCentralPubMed
11.
go back to reference Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC: Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002, 20: 819–825. 10.1183/09031936.02.00301302PubMedCrossRef Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC: Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002, 20: 819–825. 10.1183/09031936.02.00301302PubMedCrossRef
13.
go back to reference Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483.PubMedCrossRef Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483.PubMedCrossRef
14.
go back to reference Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respiratory Medicine 1991, 85: 25–31.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respiratory Medicine 1991, 85: 25–31.PubMedCrossRef
15.
go back to reference Kind P: Chapter 22. The EuroQoL instrument: an index of health-related quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition. Edited by: Spilker B. Philadelphia, Lippincott-Raven Publishers; 1996:191–201. Kind P: Chapter 22. The EuroQoL instrument: an index of health-related quality of life. In Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition. Edited by: Spilker B. Philadelphia, Lippincott-Raven Publishers; 1996:191–201.
16.
go back to reference Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B: Costs of COPD in Sweden According to Disease Severity. Chest 2002, 122: 1994–2002. 10.1378/chest.122.6.1994PubMedCrossRef Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B: Costs of COPD in Sweden According to Disease Severity. Chest 2002, 122: 1994–2002. 10.1378/chest.122.6.1994PubMedCrossRef
17.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. American Review of Respiratory Disease 1992, 145: 1321–1327.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. American Review of Respiratory Disease 1992, 145: 1321–1327.PubMedCrossRef
19.
go back to reference Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal 2002, 19: 398–404. 10.1183/09031936.02.00063702PubMedCrossRef Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal 2002, 19: 398–404. 10.1183/09031936.02.00063702PubMedCrossRef
20.
go back to reference Brooks R: The measurement and valuation of health status using EQ-5D: A European perspective. In Evidence from the EuroQol BIO MED Research Programme. Edited by: Brooks R, Rabin R and de Charro F. Dordrecht, Kluwer Academic Publishers; 2003:303. Brooks R: The measurement and valuation of health status using EQ-5D: A European perspective. In Evidence from the EuroQol BIO MED Research Programme. Edited by: Brooks R, Rabin R and de Charro F. Dordrecht, Kluwer Academic Publishers; 2003:303.
21.
go back to reference Stahl E, Wadbo M, Bengtsson T, Strom K, Lofdahl CG: Health-related quality of life, symptoms, exercise capacity and lung function during treatment for moderate to severe COPD. Journal of Outcomes Research 2001, 5: 11–24. Stahl E, Wadbo M, Bengtsson T, Strom K, Lofdahl CG: Health-related quality of life, symptoms, exercise capacity and lung function during treatment for moderate to severe COPD. Journal of Outcomes Research 2001, 5: 11–24.
22.
go back to reference Ferrucci L, Baldasseroni S, Bandinelli S, De Alfieri W, Cartei A, Calvani D, Baldini A, Masotti G, Marchionni N: Disease severity and health-related quality of life across different chronic conditions. J Am Geriatr Soc 2000, 48: 1490–1495.PubMed Ferrucci L, Baldasseroni S, Bandinelli S, De Alfieri W, Cartei A, Calvani D, Baldini A, Masotti G, Marchionni N: Disease severity and health-related quality of life across different chronic conditions. J Am Geriatr Soc 2000, 48: 1490–1495.PubMed
23.
go back to reference Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995, 273: 59–65. 10.1001/jama.273.1.59PubMedCrossRef Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995, 273: 59–65. 10.1001/jama.273.1.59PubMedCrossRef
24.
go back to reference Ferrer M, Anto JM, Alonso J: Quality of life in COPD patients of different stages of the disease. Eur Respir J 1995, 8: 354s. Ferrer M, Anto JM, Alonso J: Quality of life in COPD patients of different stages of the disease. Eur Respir J 1995, 8: 354s.
25.
go back to reference Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. American Journal of Respiratory & Critical Care Medicine 1995, 151: 61–65.CrossRef Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. American Journal of Respiratory & Critical Care Medicine 1995, 151: 61–65.CrossRef
26.
go back to reference Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F: Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal 2003, 22: 444–449. 10.1183/09031936.03.00101203PubMedCrossRef Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F: Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal 2003, 22: 444–449. 10.1183/09031936.03.00101203PubMedCrossRef
27.
go back to reference Ferrer M, Alonso J, Anto JM: Relationship between chronic obstructive pulmonary disease stage and health-related quality of life. Cardiology Review 1998, 15: 42–45. 10.1159/000018585 Ferrer M, Alonso J, Anto JM: Relationship between chronic obstructive pulmonary disease stage and health-related quality of life. Cardiology Review 1998, 15: 42–45. 10.1159/000018585
28.
go back to reference Wijnhoven HAH, Kriegsman DMW, Hesselink AE, Penninx BWJH, de Haan M: Determinants of different dimensions of disease severity in asthma and COPD - Pulmonary function and health-related quality of life. Chest 2001, 119: 1034–1042. 10.1378/chest.119.4.1034PubMedCrossRef Wijnhoven HAH, Kriegsman DMW, Hesselink AE, Penninx BWJH, de Haan M: Determinants of different dimensions of disease severity in asthma and COPD - Pulmonary function and health-related quality of life. Chest 2001, 119: 1034–1042. 10.1378/chest.119.4.1034PubMedCrossRef
29.
go back to reference Malo JL, Boulet LP, Dewitte JD, Cartier A, L'Archeveque J, Cote J, Bedard G, Boucher S, Champagne F, Tessier G, et al.: Quality of life of subjects with occupational asthma. Journal of Allergy & Clinical Immunology 1993, 91: 1121–1127. 10.1016/0091-6749(93)90313-5CrossRef Malo JL, Boulet LP, Dewitte JD, Cartier A, L'Archeveque J, Cote J, Bedard G, Boucher S, Champagne F, Tessier G, et al.: Quality of life of subjects with occupational asthma. Journal of Allergy & Clinical Immunology 1993, 91: 1121–1127. 10.1016/0091-6749(93)90313-5CrossRef
30.
go back to reference Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47: 76–83.PubMedCentralPubMedCrossRef Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47: 76–83.PubMedCentralPubMedCrossRef
31.
go back to reference Prigatano GP, Wright EC, Levin D: Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984, 144: 1613–1619. 10.1001/archinte.144.8.1613PubMedCrossRef Prigatano GP, Wright EC, Levin D: Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984, 144: 1613–1619. 10.1001/archinte.144.8.1613PubMedCrossRef
32.
go back to reference Kohler CL, Fish L, Greene PG: The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease. Health Psychology 2002, 21: 610–614. 10.1037//0278-6133.21.6.610PubMedCrossRef Kohler CL, Fish L, Greene PG: The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease. Health Psychology 2002, 21: 610–614. 10.1037//0278-6133.21.6.610PubMedCrossRef
Metadata
Title
Health-related quality of life is related to COPD disease severity
Authors
Elisabeth Ståhl
Anne Lindberg
Sven-Arne Jansson
Eva Rönmark
Klas Svensson
Fredrik Andersson
Claes-Göran Löfdahl
Bo Lundbäck
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2005
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-3-56

Other articles of this Issue 1/2005

Health and Quality of Life Outcomes 1/2005 Go to the issue